Skip to content
RDL Network logo
Efficacy of Agomelatine 25–50 mg for the Treatment of Anxious Symptoms and Functional Impairment in Generalized Anxiety Disorder: A Meta-Analysis of Three Placebo-Controlled Studies — Dan Joseph Stein (2021) | RDL Network